子痫前期诊断前及诊断时母体血脂蛋白胆固醇水平:一项系统综述
该系统综述检索至2024年4月,纳入41项研究,评估子痫前期诊断前及诊断时母体高密度脂蛋白胆固醇、低密度脂蛋白胆固醇和极低密度脂蛋白胆固醇水平变化。结果显示诊断前高密度脂蛋白和低密度脂蛋白无一致变化,极低密度脂蛋白在妊娠晚期诊断前及诊断时显著升高,高密度脂蛋白在诊断后显著降低。
要点
- 子痫前期诊断前,高密度和低密度脂蛋白胆固醇水平无一致变化。
- 晚孕期第二孕晚期(>23周)或第三孕晚期诊断前,极低密度脂蛋白显著升高(2/2项研究)。
- 第三孕晚期诊断后,极低密度脂蛋白在9/11项研究中显著升高,高密度脂蛋白在15/19项研究中显著降低。
核心结论
- 极低密度脂蛋白致动脉粥样硬化性强,其在子痫前期诊断前及诊断时升高提示参与子痫前期相关内皮功能障碍的发病机制。
- 极低密度脂蛋白和高密度脂蛋白均有希望作为子痫前期的前瞻性诊断生物标志物,其中极低密度脂蛋白仅作为前瞻性诊断标志物。
研究设计与样本
- 系统综述,检索Ovid MEDLINE、Embase、护理与联合健康文献累积索引及Google Scholar自建库至2024年4月。
- 纳入报告正常妊娠和子痫前期妊娠高密度脂蛋白、低密度脂蛋白和极低密度脂蛋白水平的研究,共纳入41项研究。
- 由2名评价者参与研究筛选,采用纽卡斯尔-渥太华量表评价病例对照、队列和横断面研究质量。
主要发现
- 在妊娠第一、第二或第三孕晚期子痫前期诊断前,高密度脂蛋白或低密度脂蛋白水平未发现一致变化。
- 在报告子痫前期诊断前晚第二孕晚期(>23周妊娠)或第三孕晚期水平的2项研究中,极低密度脂蛋白均显著升高(2/2项研究)。
- 第三孕晚期子痫前期诊断后,极低密度脂蛋白在11项研究中的9项显著升高,高密度脂蛋白在19项研究中的15项显著降低。
- 研究质量总体良好,但59%的研究未控制采血时的孕龄。
局限性
- 59%的研究未控制采血时的孕龄。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Wide-spread endothelial dysfunction is thought to underlie the maternal symptoms of preeclampsia. Endothelial dysfunction is strongly associated with abnormal circulating lipoprotein cholesterol levels. This systematic review aimed to assess whether maternal circulating high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and very-low-density lipoprotein cholesterol levels were altered before or at the time of preeclampsia diagnosis. This may provide an understanding of the pathogenesis of preeclampsia and the predictive and diagnostic utility of lipoprotein cholesterol levels in distinguishing pregnancies complicated by preeclampsia from normal pregnancies. DATA SOURCES: Literature searches were conducted in Ovid MEDLINE, Embase, Cumulative Index of Nursing and Allied Health Literature, and Google Scholar from inception to April 2024 for studies reporting high-density lipoprotein, low-density lipoprotein, and very-low-density lipoprotein levels in normal pregnancies and pregnancies complicated by preeclampsia. STUDY ELIGIBILITY CRITERIA: The selected studies included the following: population of pregnant women, exposure to preeclampsia, blood samples collected during a specific trimester of pregnancy, and at least 1 primary outcome (high-density lipoprotein, low-density lipoprotein, or very-low-density lipoprotein). Of note, 2 reviewers were involved in the study selection. The excluded studies included pregnancies complicated by other risk factors for preeclampsia (eg, preexisting hypertension, diabetes mellitus, and obesity) and other pregnancy-related hypertensive disorders (pregnancy-induced hypertension, eclampsia, and hemolysis, elevated liver enzymes, and low platelet count). METHODS: The quality of the included studies was evaluated using the Newcastle-Ottawa Scale for case-control, cohort, and cross-sectional studies. RESULTS: A total of 41 studies were included. The quality of the studies was generally good. However, 59% of the studies did not control for the gestational age at which the blood samples were collected. No consistent change in high-density lipoprotein or low-density lipoprotein levels was found before preeclampsia diagnosis in the first, second, or third trimesters of pregnancy. Very-low-density lipoprotein was significantly elevated in 2 of 2 studies that reported levels before preeclampsia diagnosis in the late second (>23 weeks of gestation) or third trimester of pregnancy. After preeclampsia diagnosis in the third trimester of pregnancy, very-low-density lipoprotein levels were significantly elevated in 9 of 11 studies, and high-density lipoprotein levels were significantly decreased in 15 of 19 studies. CONCLUSION: Very-low-density lipoprotein is highly atherogenic, and its elevation before and at the time of preeclampsia diagnosis suggests a role in the pathogenesis of the endothelial dysfunction associated with preeclampsia. Both very-low-density lipoprotein and high-density lipoprotein show promise as prospective (very-low-density lipoprotein-only) diagnostic biomarkers for preeclampsia. El resumen está disponible en Español al final del artículo.
引用
- Yang S, Zhou W, Dimitriadis E, et al. Maternal blood lipoprotein cholesterol prior to and at the time of diagnosis of preeclampsia: a systematic review. Am J Obstet Gynecol MFM. 2025. PMID: 39986407. doi:10.1016/j.ajogmf.2025.101654
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。